All news

(Image: Getty/Anghi)

GSK gets first approval for two-drug HIV treatment

By Ben Hargreaves

GSK’s Dovato is approved by the US FDA for the treatment of individuals with HIV with no previous antiretroviral therapy, in a first for a two-drug, fixed-dose, complete regimen.

(Image: Getty/Bedo)

The most read stories in March

By Staff Reporter

After the M&A excitement that began the year, the developments in March were a mixture of long-running events, such as the sartan manufacturing issues, breakthrough research and regulatory struggles.